News Archive
Displaying the 10 most recent press releases...
Monday, January 23, 2012
EntreMed Secures $10 Million Strategic Financing
Monday, November 14, 2011
EntreMed Reports Third Quarter 2011 Financial Results
Monday, October 3, 2011
EntreMed’s ENMD-2076 Demonstrates Promising Activity in a Phase 2 Study in Platinum-Resistant Ovarian Cancer Patients
Monday, August 15, 2011
EntreMed Reports Second Quarter 2011 Financial Results
Tuesday, June 28, 2011
EntreMed Enters into $7.5 Million Equity Facility and Initiates $1.1 Million Drawdown
Tuesday, June 7, 2011
Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
Friday, June 3, 2011
EntreMed’s ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients
Thursday, May 19, 2011
EntreMed ENMD-2076 Phase 2 Data to Be Presented at ASCO Annual Meeting
Monday, May 16, 2011
EntreMed Reports First Quarter 2011 Financial Results
Wednesday, March 30, 2011
EntreMed Reports Fourth Quarter and Year-End 2010 Financial Results